Recombinant monoclonal antibody to CCL20. F003A09 is a human antibody that can be potentially used in the treatment of cancer and immune system disease.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MHH-157 | Recombinant Human Anti-human CCL20 Antibody | WB, ELISA, IHC, FuncS | IgG |
MOB-1108CT | Mouse Anti-CCL20 Recombinant Antibody (clone 3N2D9) | ELISA | Mouse IgG1 |
HPAB-0007-CN | Mouse Anti-CCL20 Recombinant Antibody (HPAB-0007-CN) | sELISA | Mouse IgG |
HPAB-0008-CN | Mouse Anti-CCL20 Recombinant Antibody (HPAB-0008-CN) | sELISA | Mouse IgG |
HPAB-3390LY | Human Anti-CCL20 Recombinant Antibody (clone CBL153) | Inhib | Humanized IgG |
There are currently no Customer reviews or questions for TAB-464LC-S(P). Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.